Facilities

Founded in 2021, NEPHRIX Biosolutions has quickly become a recognized preclinical research CRO (Contract Research Organization) renowned for its specialized renal diseases preclinical services.

The company proposes innovative in vitro and in vivo models for preclinical research on Chronic Kidney Disease (CKD), along with an extensive array of assays aimed at showcasing the efficacy of clients’ drug candidates. The company benefits from the experience of more than 10 years of its founders in contracted R&D.

NEPHRIX Biosolutions is integrated whitin the business incubator PROLOGUE BIOTECH, dedicated to Biotechs and Medical R&D companies. The company also have a close relationship and access to state-of-the-art imaging and molecular facilities of the University Paul Sabatier (Toulouse III).

R&D activities are perfomed in independant and dedicated areas with securized access.